Publications

  1. Tremblay C, Adler CH, Shill HA, Driver-Dunckley E, Mehta S, Choudhury P, Belden C, Shprecher DR, Lee-Iannotti JK, Atri A, Serrano GE, Beach TG. Predicting Post-Mortem alpha-Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia. Mov Disord Clin Pract. 2024 Nov 5 Epub 2024 Nov 05
    View PubMed
  2. Choi A, Zhang N, Adler CH, Beach TG, Shill HA, Driver-Dunckley E, Mehta S, Belden C, Atri A, Sabbagh MN, Caviness JN. Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohort. Parkinsonism Relat Disord. 2024 Nov; 128:107120 Epub 2024 Aug 31
    View PubMed
  3. Beach TG, Serrano GE, Zhang N, Driver-Dunckley ED, Sue LI, Shill HA, Mehta SH, Belden C, Tremblay C, Choudhury P, Atri A, Adler CH. Clinicopathological Heterogeneity of Lewy Body Diseases: The Profound Influence of Comorbid Alzheimer's Disease. medRxiv. 2024 Sep 4 Epub 2024 Sept 04
    View PubMed
  4. Adler CH, Halverson M, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano GE, Shprecher DR, Belden CM, Sabbagh MN, Long K, Beach TG. Conjugal Synucleinopathies: A Clinicopathologic Study. Mov Disord. 2024 Jul; 39 (7):1212-1217 Epub 2024 Apr 10
    View PubMed
  5. Tremblay C, Aslam S, Walker JE, Lorenzini I, Intorcia AJ, Arce RA, Choudhury P, Adler CH, Shill HA, Driver-Dunckley E, Mehta S, Piras IS, Belden CM, Atri A, Beach TG, Serrano GE. RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction. Neurobiol Dis. 2024 Jun 15; 196:106514 Epub 2024 Apr 24
    View PubMed
  6. Mastenbroek SE, Vogel JW, Collij LE, Serrano GE, Tremblay C, Young AL, Arce RA, Shill HA, Driver-Dunckley ED, Mehta SH, Belden CM, Atri A, Choudhury P, Barkhof F, Adler CH, Ossenkoppele R, Beach TG, Hansson O. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology. Nat Commun. 2024 Jun 15; 15 (1):5133 Epub 2024 June 15
    View PubMed
  7. Adler CH, Serrano GE, Shill HA, Driver-Dunckley E, Mehta SH, Zhang N, Glass M, Sue LI, Intorcia A, Beach TG. Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands. Neurosci Lett. 2024 Mar 10; 825:137702 Epub 2024 Feb 21
    View PubMed
  8. Mauricio EA, Coon EA, Driver-Dunckley ED, English SW Jr, Cutsforth-Gregory JK, Grill MF, Martinez-Thompson JM, Jones LK, for Mayo Clinic Adult Neurology Residency Program Leadership. Education Research: Virtual Residency Interviews and the Second Look: The Mayo Clinic Neurology Tri-Site Experience. Neurol Educ. 2023 Dec 22; 2 (4):e200095 Epub 2023 Oct 16
    View PubMed
  9. Choudhury P, Zhang N, Adler CH, Chen K, Belden C, Driver-Dunckley E, Mehta SH, Shprecher DR, Serrano GE, Shill HA, Beach TG, Atri A. Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort. Alzheimers Dement. 2023 Oct; 19 (10):4377-4387 Epub 2023 July 08
    View PubMed
  10. Beach TG, Sue LI, Scott S, Intorcia AJ, Walker JE, Arce RA, Glass MJ, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Stewart A, Martinez KN, Krupp A, McHattie R, Mariner M, Lorenzini I, Kuramoto A, Long KE, Tremblay C, Caselli RJ, Woodruff BK, Rapscak SZ, Belden CM, Goldfarb D, Choudhury P, Driver-Dunckley ED, Mehta SH, Sabbagh MN, Shill HA, Atri A, Adler CH, Serrano GE. Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy. J Neuropathol Exp Neurol. 2023 May 25; 82 (6):457-466
    View PubMed
  11. Driver-Dunckley ED, Zhang N, Serrano GE, Dunckley NA, Sue LI, Shill HA, Mehta SH, Belden C, Tremblay C, Atri A, Adler CH, Beach TG. Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy. J Neuropathol Exp Neurol. 2023 Apr 20; 82 (5):438-451
    View PubMed
  12. Tremblay C, Serrano GE, Dunckley N, Zhang N, Fiock KL, Adler CH, Driver-Dunckley E, Mehta SH, Shill HA, Beach TG. Postmortem Cerebellar Volume Is Not Reduced in Essential Tremor: A Comparison with Multiple System Atrophy and Controls. J Parkinsons Dis. 2023; 13 (3):333-340
    View PubMed
  13. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Update: Functional and somatic symptom disorders BMJ Best Practice. 2023.
  14. Aslam S, Zhang N, Adler CH, Beach TG, Driver-Dunckley E, Mehta SH, Shill H. Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study. Neurol Clin Pract. 2022 Oct; 12 (5):e85-e92
    View PubMed
  15. Hasan S, Adler CH, Zhang N, Serrano GE, Sue LI, Shill HA, Mehta SH, Beach TG, Driver-Dunckley ED. Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson's Disease: An Update. Innov Clin Neurosci. 2022 Oct-Dec; 19 (10-12):19-23
    View PubMed
  16. Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Caselli R, Woodruff BK, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Rapscak SZ, Bime C, Peters JL, Alevritis E, Arce RA, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Russell A, Suszczewicz KE, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Hobgood HM, Mizgerd JP, Sahoo MK, Zhang H, Solis D, Montine TJ, Berry GJ, Reiman EM, Roltgen K, Boyd SD, Pinsky BA, Zehnder JL, Talbot P, Desforges M, DeTure M, Dickson DW, Beach TG. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. J Neuropathol Exp Neurol. 2022 Aug 16; 81 (9):666-695
    View PubMed
  17. Tremblay C, Serrano GE, Intorcia AJ, Mariner MR, Sue LI, Arce RA, Atri A, Adler CH, Belden CM, Shill HA, Driver-Dunckley E, Mehta SH, Beach TG. Olfactory Bulb Amyloid-beta Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment. J Neuropathol Exp Neurol. 2022 Jul 19; 81 (8):643-649
    View PubMed
  18. Callister MN, Stonnington CB, Cuc A, Alcott SB, Driver-Dunckley ED, Mehta SH, Hasan S, Marks LA, Wingerchuk DM, O'Carroll CB. In Patients With Functional Movement Disorders, Is Specialized Physical Therapy Effective in Improving Motor Symptoms?: A Critically Appraised Topic. Neurologist. 2022 Jan 20; 27 (2):82-88
    View PubMed
  19. Lea R, Benge JF, Adler CH, Beach TG, Belden CM, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease. J Clin Exp Neuropsychol. 2021 Nov; 43 (9):918-925 Epub 2022 Feb 09
    View PubMed
  20. Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano G, Shprecher DR, Sue LI, Belden CM. Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease: An Updated Clinicopathologic Study. Neurol Clin Pract. 2021 Aug; 11 (4):e414-e421
    View PubMed
  21. Koga S, Cheshire WP, Tipton PW, Driver-Dunckley ED, Wszolek ZK, Uitti RJ, Graff-Radford NR, van Gerpen JA, Dickson DW. Clinical features of autopsy-confirmed multiple system atrophy in the Mayo Clinic Florida brain bank. Parkinsonism Relat Disord. 2021 Aug; 89:155-161 Epub 2021 July 10
    View PubMed
  22. Shill HA, Zhang N, Driver-Dunckley E, Mehta S, Adler CH, Beach TG. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. Mov Disord. 2021 Jul; 36 (7):1700-1704 Epub 2021 Mar 23
    View PubMed
  23. Muthusamy K, Fasolino JP, Driver-Dunckley ED, Dhamija R. Ekbom Syndrome: Ataxia, Myoclonus, and Cervical Lipomas. Ann Neurol. 2021 Mar; 89 (3):623-624 Epub 2021 Jan 04
    View PubMed
  24. Henderson AR, Wang Q, Meechoovet B, Siniard AL, Naymik M, De Both M, Huentelman MJ, Caselli RJ, Driver-Dunckley E, Dunckley T. DNA Methylation and Expression Profiles of Whole Blood in Parkinson's Disease. Front Genet. 2021; 12:640266 Epub 2021 Apr 26
    View PubMed
  25. Gupta HV, Beach TG, Mehta SH, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Liebsack C, Dugger BN, Serrano GE, Sue LI, Siderowf A, Pontecorvo MJ, Mintun MA, Joshi AD, Adler CH. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies. J Alzheimers Dis. 2021; 80 (4):1603-1612
    View PubMed
  26. Beach TG, Adler CH, Sue LI, Shill HA, Driver-Dunckley E, Mehta SH, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Serrano GE. Vagus Nerve and Stomach Synucleinopathy in Parkinson's Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the "Body-First" Hypothesis. J Parkinsons Dis. 2021; 11 (4):1833-1843
    View PubMed
  27. Shprecher DR, Adler CH, Zhang N, Shill HA, Belden CM, Driver-Dunckley E, Mehta SH, Davis KJ, Sue LI, Zamrini E, Beach TG. Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate? Clin Neurol Neurosurg. 2020 May; 192:105728 Epub 2020 Feb 06
    View PubMed
  28. Knox MG, Adler CH, Shill HA, Driver-Dunckley E, Mehta SA, Belden C, Zamrini E, Serrano G, Sabbagh MN, Caviness JN, Sue LI, Davis KJ, Dugger BN, Beach TG. Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment. Mov Disord. 2020 May; 35 (5):845-850 Epub 2020 Feb 08
    View PubMed
  29. Krishnamurthi N, Murphey C, Driver-Dunckley E. A comprehensive Movement and Motion training program improves mobility in Parkinson's disease. Aging Clin Exp Res. 2020 Apr; 32 (4):633-643 Epub 2019 June 11
    View PubMed
  30. Beach TG, Adler CH, Zhang N, Serrano GE, Sue LI, Driver-Dunckley E, Mehta SH, Zamrini EE, Sabbagh MN, Shill HA, Belden CM, Shprecher DR, Caselli RJ, Reiman EM, Davis KJ, Long KE, Nicholson LR, Intorcia AJ, Glass MJ, Walker JE, Callan MM, Oliver JC, Arce R, Gerkin RC. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia. PLoS One. 2020; 15 (4):e0231720 Epub 2020 Apr 22
    View PubMed
  31. Serrano GE, Shprecher D, Callan M, Cutler B, Glass M, Zhang N, Walker J, Intorcia A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Belden CM, Zamrini E, Sue LI, Vargas D, Beach TG. Cardiac sympathetic denervation and synucleinopathy in Alzheimer's disease with brain Lewy body disease. Brain Commun. 2020; 2 (1):fcaa004 Epub 2020 Jan 28
    View PubMed
  32. Gupta HV, Zhang N, Driver-Dunckley E, Mehta SH, Beach TG, Adler CH. Contrast Acuity With Different Colors in Parkinson's Disease. Mov Disord Clin Pract. 2019 Nov; 6 (8):672-677 Epub 2019 Sept 06
    View PubMed
  33. Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Belden CM, Powell J, Jacobson SA, Zamrini E, Shprecher D, Davis KJ, Dugger BN, Hentz JG. Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging. J Neuropathol Exp Neurol. 2019 Oct 1; 78 (10):891-899
    View PubMed
  34. Driver-Dunckley ED, Zhang N, Shill HA, Mehta SH, Belden CM, Zamrini EY, Davis K, Beach TG, Adler CH. Correlation Between the Movement Disorder Society's Unified Parkinson's Disease Rating Scale and Nonmotor Scales in Patients with Parkinson's Disease. Innov Clin Neurosci. 2019 Sep 1; 16 (9-10):27-29
    View PubMed
  35. Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Mov Disord. 2019 Aug; 34 (8):1144-1153 Epub 2019 Feb 06
    View PubMed
  36. El-Nazer R, Adler CH, Beach TG, Belden CM, Artz J, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Zamrini E, Benge JF. Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease. Parkinsonism Relat Disord. 2019 Aug; 65:73-78 Epub 2019 May 10
    View PubMed
  37. Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG. Tau immunoreactivity in peripheral tissues of human aging and select tauopathies. Neurosci Lett. 2019 Mar 23; 696:132-139 Epub 2018 Dec 21
    View PubMed
  38. Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease. PLoS One. 2019; 14 (6):e0217566 Epub 2019 June 25
    View PubMed
  39. Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH. Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study. Acta Neurol Scand. 2019 Jan; 139 (1):76-81 Epub 2018 Oct 07
    View PubMed
  40. Driver-Dunckley ED, Zhang N, Adler CH, Serrano GE, Sue LI, Shill HA, Mehta SH, Belden CM, Zamrini EY, Davis K, Beach TG. Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson's Disease1. J Parkinsons Dis. 2019; 9 (3):543-552
    View PubMed
  41. Shprecher DR, Adler CH, Zhang N, Hentz JG, Serrano GE, Dugger BN, Shill HA, Savica R, Caviness JN, Sabbagh MN, Belden CM, Driver-Dunckley E, Mehta SH, Sue LI, Davis KJ, Zamrini E, Beach TG. Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. Parkinsonism Relat Disord. 2018 Oct; 55:92-96 Epub 2018 May 17
    View PubMed
  42. Caviness JN, Beach TG, Hentz JG, Shill HA, Driver-Dunckley ED, Adler CH. Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease. Clin EEG Neurosci. 2018 Sep; 49 (5):321-327 Epub 2017 Feb 01
    View PubMed
  43. Gupta HV, Mehta SH, Zhang N, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Dugger BN, Beach TG, Serrano GE, Sue LI, Davis K, Adler CH. Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease? Mov Disord Clin Pract. 2018 Mar-Apr; 5 (2):165-170 Epub 2018 Feb 22
    View PubMed
  44. DiBaise JK, Crowell MD, Driver-Dunckley E, Mehta SH, Hoffman-Snyder C, Lin T, Adler CH. Weight Loss in Parkinson's Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth. J Parkinsons Dis. 2018; 8 (4):571-581
    View PubMed
  45. Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Jacobson SA, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG. GBA mutations in Parkinson disease: earlier death but similar neuropathological features. Eur J Neurol. 2017 Nov; 24 (11):1363-1368 Epub 2017 Aug 17
    View PubMed
  46. Aslam S, Zhang N, Adler CH, Caviness JN, Driver-Dunckley E, Mehta SH, Sabbagh MN, Belden C, Zamrini E, Beach TG, Shill HA. Essential tremor and depression. Mov Disord Clin Pract. 2017 Nov-Dec; 4 (6):838-842 Epub 2017 July 17
    View PubMed
  47. Gerkin RC, Adler CH, Hentz JG, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Caviness JN, Dugger BN, Serrano G, Belden C, Smith BH, Sue L, Davis KJ, Zamrini E, Beach TG. Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype. Ann Clin Transl Neurol. 2017 Oct; 4 (10):714-721 Epub 2017 Sept 08
    View PubMed
  48. Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG. Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings. Mov Disord. 2017 May; 32: (5)722-723.
    View PubMed
  49. Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG, Arizona Study of Aging Neurodegenerative Disorders. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation. Mov Disord. 2017 Feb; 32 (2):274-277 Epub 2016 Dec 02
    View PubMed
  50. Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE. Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition. J Neuropathol Exp Neurol. 2016 Aug; 75 (8):748-754 Epub 2016 June 12
    View PubMed
  51. Henderson-Smith A, Corneveaux JJ, De Both M, Cuyugan L, Liang WS, Huentelman M, Adler C, Driver-Dunckley E, Beach TG, Dunckley TL. Next-generation profiling to identify the molecular etiology of Parkinson dementia. Neurol Genet. 2016 Jun; 2 (3):e75 Epub 2016 May 24
    View PubMed
  52. Utianski RL, Caviness JN, van Straaten EC, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH, Hentz JG. Graph theory network function in Parkinson's disease assessed with electroencephalography. Clin Neurophysiol. 2016 May; 127: (5)2228-36.
    View PubMed
  53. Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH. Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts. Eur J Neurol. 2016 Feb; 23 (2):387-92 Epub 2015 Oct 31
    View PubMed
  54. Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG. Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings. Mov Disord. 2016 Feb; 31 (2):250-6 Epub 2016 Jan 22
    View PubMed
  55. Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Intorcia A, Filon J, Scott S, Garcia A, Hoffman B, Belden CM, Davis KJ, Sabbagh MN, Arizona Parkinson's Disease Consortium. Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders. J Parkinsons Dis. 2016; 6 (1):153-63
    View PubMed
  56. Shill HA, Hentz JG, Caviness JN, Driver-Dunckley E, Jacobson S, Belden C, Sabbagh MN, Beach TG, Adler CH. Unawareness of Hyposmia in Elderly People With and Without Parkinson's Disease. Mov Disord Clin Pract. 2016 Jan-Feb; 3 (1):43-47 Epub 2015 July 17
    View PubMed
  57. Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH. Simplified conversion method for unified Parkinson's disease rating scale motor examinations. Mov Disord. 2015 Dec; 30 (14):1967-70 Epub 2015 Nov 17
    View PubMed
  58. Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG. REM sleep behavior disorder and neuropathology in Parkinson's disease. Mov Disord. 2015 Sep; 30 (10):1413-7 Epub 2015 Aug 12
    View PubMed
  59. Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment. BMC Neurol. 2015 Aug 20; 15:146
    View PubMed
  60. Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology. 2015 Aug; 35 (4):354-89 Epub 2015 Jan 26
    View PubMed
  61. Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA, Driver-Dunckley E, Sabbagh MN, Sue LI, Caviness JN. Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology. Mov Disord Clin Pract. 2015 Mar; 2 (1):33-38 Epub 2014 Oct 29
    View PubMed
  62. Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease. J Parkinsons Dis. 2015; 5 (1):117-24
    View PubMed
  63. Driver-Dunckley E, Adler CH, Hentz JG, Dugger BN, Shill HA, Caviness JN, Sabbagh MN, Beach TG, Arizona Parkinson Disease Consortium. Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease. Parkinsonism Relat Disord. 2014 Nov; 20 (11):1260-2 Epub 2014 Aug 16
    View PubMed
  64. Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JN, Hu C, Arizona Parkinson's Disease Consortium. Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations. Parkinsonism Relat Disord. 2014 Sep; 20 (9):1009-14 Epub 2014 June 28
    View PubMed
  65. Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, Dugger BN. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014 Jul 29; 83 (5):406-12 Epub 2014 June 27
    View PubMed
  66. Dugger B, Hentz J, Adler C, Sabbagh M, Shill H, Jacobson S, Caviness J, Belden C, Driver-Dunckley E, Davis K, Sue L, Beach T. A novel medulloblastoma model mimicking human disease J Neuropathol Exp Neurol.;73(6)618.
  67. Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, Beach TG, Arizona Parkinson's Disease Consortium. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord. 2014 May; 20 (5):525-9 Epub 2014 Feb 22
    View PubMed
  68. Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, Henry-Watson J, Serrano G, Sue LI, Nagel T, Duffy A, Shill HA, Akiyama H, Walker DG, Beach TG. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology. 2014 Mar 11; 82 (10):858-64 Epub 2014 Feb 05
    View PubMed
  69. Dugger BN, Hentz JG, Adler CH, Sabbagh MN, Shill HA, Jacobson S, Caviness JN, Belden C, Driver-Dunckley E, Davis KJ, Sue LI, Beach TG. Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. J Neuropathol Exp Neurol. 2014 Mar; 73 (3):244-52
    View PubMed
  70. Shill HA, Hentz JG, Jacobson SA, Belden C, Sabbagh MN, Beach TG, Driver-Dunckley E, Adler CH. Essential Tremor in the Elderly and Risk for Dementia. J Neurodegener Dis. 2014; 2014:328765 Epub 2014 Apr 09
    View PubMed
  71. Symanski C, Shill HA, Dugger B, Hentz JG, Adler CH, Jacobson SA, Driver-Dunckley E, Beach TG. Essential tremor is not associated with cerebellar Purkinje cell loss. Mov Disord. 2014; 29(4):496-500.
    View PubMed
  72. Shneyder N, Adler CH, Hentz JG, Shill H, Caviness JN, Sabbagh MN, Beach TG, Driver-Dunckley E. Autonomic complaints in patients with restless legs syndrome. Sleep Med. 2013 Dec; 14 (12):1413-6 Epub 2013 Sept 21
    View PubMed
  73. Beach TG, Adler CH, Dugger BN, Serrano G, Hidalgo J, Henry-Watson J, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Arizona Parkinson's Disease Consortium. Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol. 2013 Feb; 72(2):130-6.
    View PubMed
  74. Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG, Arizona Parkinson Disease Consortium. Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol. 2013 Feb; 240:190-204. Epub 2012 Nov 28.
    View PubMed
  75. Henderson-Smith A, Chow D, Meechoovet B, Aziz M, Jacobson SA, Shill HA, Sabbagh MN, Caviness JN, Adler CH, Driver-Dunckley ED, Beach TG, Yin H, Dunckley T. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening. PLoS One. 2013; 8: (10)e77711.
    View PubMed
  76. Damian A, Adler CH, Hentz JG, Shill HA, Caviness JN, Sabbagh MN, Evidente VG, Beach TG, Driver-Dunckley E. Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease. Parkinsonism Relat Disord. 2012 Dec; 18: (10)1089-93.
    View PubMed
  77. Driver-Dunckley ED, Adler CH. Movement disorders and sleep. Neurol Clin. 2012 Nov; 30(4):1345-58.
    View PubMed
  78. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke. Update: Conversion and somatization disorders. BMJ Best Practice. Accessible on epocrates.com. Available at: www.bestpractice.bmj.com.. 2012.
  79. Noe KH, Grade M, Stonnington CM, Driver-Dunckley E, Locke DE. Confirming psychogenic nonepileptic seizures with video-EEG: sex matters. Epilepsy Behav. 2012 Mar; 23 (3):220-3 Epub 2012 Feb 15
    View PubMed
  80. Shneyder N, Lyons MK, Driver-Dunckley E, Evidente VG. Cerebellar Ataxia from Multiple Potential Causes: Hypothyroidism, Hashimoto's Thyroiditis, Thalamic Stimulation, and Essential Tremor. Tremor Other Hyperkinet Mov (N Y). 2012; 2 Epub 2012 Mar 22
    View PubMed
  81. Caviness JN, Adler CH, Hentz JG, Shill HA, Evidente VG, Driver-Dunckley ED, Sabbagh MN, Sue L, Beach TG. Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders. Clin Neurophysiol. 2011 Dec; 122 (12):2426-32 Epub 2011 May 26
    View PubMed
  82. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Update: Conversion and somatization disorders. BMJ Best Practice, 2011 acessible on epocrates.com. Available at www.bestpractice.bmj.com. 2011 Oct.
  83. Evidente VG, Premkumar AP, Adler CH, Caviness JN, Driver-Dunckley E, Lyons MK. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease. Acta Neurol Scand. 2011 Sep; 124(3):211-4. Epub 2010 Oct 25.
    View PubMed
  84. Klassen BT, Hentz JG, Shill HA, Driver-Dunckley E, Evidente VG, Sabbagh MN, Adler CH, Caviness JN. Quantitative EEG as a predictive biomarker for Parkinson disease dementia. Neurology. 2011 Jul 12; 77 (2):118-24 Epub 2011 June 01
    View PubMed
  85. Driver-Dunckley E, Stonnington CM, Locke DE, Noe K. Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important? Psychosomatics. 2011 Jul-Aug; 52(4):337-45. Epub 2011 Jun 08.
    View PubMed
  86. Adler CH, Hentz JG, Shill HA, Sabbagh MN, Driver-Dunckley E, Evidente VG, Jacobson SA, Beach TG, Boeve B, Caviness JN. Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. Parkinsonism Relat Disord. 2011 Jul; 17 (6):456-8 Epub 2011 Apr 08
    View PubMed
  87. Caviness JN, Lue LF, Beach TG, Hentz JG, Adler CH, Sue L, Sadeghi R, Driver-Dunckley E, Evidente VG, Sabbagh MN, Shill HA, Walker DG. Parkinson's disease, cortical dysfunction, and alpha-synuclein. Mov Disord. 2011 Jul; 26 (8):1436-42 Epub 2011 May 03
    View PubMed
  88. Papay K, Mamikonyan E, Siderowf AD, Duda JE, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Weintraub D. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord. 2011 Mar; 17: (3)153-5.
    View PubMed
  89. Weintraub D, Sohr M, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE, Dominion Study Group. Amantadine use associated with impulse control disorders Ann Neurol.2010;68(6)963-8.
  90. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Conversion and somatization disorders. BMJ Best Practice. 2010 accessible on epocrates.com; www.bestpractice.bmj.com. 2010 Sep.
  91. Beach TG, Adler CH, Vedders L, Lue L, White CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG, Arizona Parkinson's Disease Consortium . Multi-organ distribution of posphorylated alpha-synuclein histopathology in subjects with Lew body disorders. Acta Neuropathol .2010 Jun;119:(6):689-702.
  92. Thaera GM, Wellik KE, Barrs DM, Dunckley ED, Wingerchuk DM, Demaerschalk BM. Are corticosteroid and antiviral treatments effective for bell palsy? A critically appraised topic. Neurologist. 2010 Mar; 16(2):138-40.
    View PubMed
  93. Driver-Dunckley ED, Hoxworth JM, Patel NP, Bosch EP, Goodman BP. Superficial siderosis mimicking amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2010 Mar; 11(3):137-44.
    View PubMed
  94. McKinnon J, Evidente V, Driver-Dunckley E, Premkumar A, Hentz J, Shill H, Sabbagh M, Caviness J, Connor D, Adler C. Olfaction in the elderly: a cross-sectional analysis comparing Parkinson's disease with controls and other disorders. Int J Neurosci. 2010 Jan; 120(1):36-9.
    View PubMed
  95. Driver-Dunckley E, Connor D, Hentz J, Sabbagh M, Silverberg N, Hernandez J, Vedders L, Evidente VG, Shill H, Caviness J, Adler C. No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome. Mov Disord. 2009 Sep 15; 24 (12):1840-2
    View PubMed
  96. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Conversion and somatization disorders. BMJ Best Practice 2009 accessible on epocrates.com. Available at: www.bestpractice.bmj.com (updated annually). 2009 Sep.
  97. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord. 2009 Jul 30; 24: (10)1461-7.
    View PubMed
  98. Almaraz AC, Driver-Dunckley ED, Woodruff BK, Wellik KE, Caselli RJ, Demaerschalk BM, Adler CH, Caviness JN, Wingerchuk DM. Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist. 2009 Jul; 15(4):234-7.
    View PubMed
  99. Alvarez MV, Driver-Dunckley EE, Caviness JN, Adler CH, Evidente VG. Case series of painful legs and moving toes: clinical and electrophysiologic observations. Mov Disord. 2008 Oct 30; 23(14):2062-6.
    View PubMed
  100. Goodman BP, Driver-Dunckley ED, Leslie KO, Patel AC, Wesselius LJ. A case of gait unsteadiness--an atypical manifestation of an unusual disease. Lancet Neurol. 2007 Nov; 6(11):1029-32.
    View PubMed
  101. Alvarez MV, Evidente VG, Driver-Dunckley ED. Differentiating Parkinson's disease from other parkinsonian disorders. Semin Neurol. 2007 Sep; 27: (4)356-62.
    View PubMed
  102. Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol. 2007 Sep-Oct; 30 (5):249-55
    View PubMed
  103. Caviness JN, Hentz JG, Evidente VG, Driver-Dunckley E, Samanta J, Mahant P, Connor DJ, Sabbagh MN, Shill HA, Adler CH. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord. 2007 Aug; 13: (6)348-54.
    View PubMed
  104. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007 Jul 15; 22 (9):1272-7
    View PubMed
  105. Sabbagh MN, Lahti T, Connor DJ, Caviness JN, Shill H, Vedders L, Mahant P, Samanta J, Burns RS, Evidente VG, Driver-Dunckley E, Reisberg B, Bircea S, Adler CH. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease. Dement Geriatr Cogn Disord. 2007; 24: (5)327-34.
    View PubMed
  106. Driver-Dunckley E, Evidente VG, Adler CH, Hillman R, Hernandez J, Fletcher G, Lyons MK. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord. 2006 Aug; 21 (8):1287-9
    View PubMed
  107. Driver-Dunckley E, Evidente VG. Hemichorea-hemiballismus may respond to topiramate. Clin Neuropharmacol. 2005 May-Jun; 28 (3):142-4
    View PubMed
  108. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology. 2003 Aug 12; 61(3):422-3.
    View PubMed
  109. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994 Aug 11; 22(15):3181-6.
    View PubMed